Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Venkatesan

Showing results (231-240 of 321) with videos related to

Pageof 33
Sort By:
Bioorganic & Medicinal Chemistry Letters|July 31, 2009
2,4-Diamino-quinazolines as inhibitors of beta-catenin/Tcf-4 pathway: Potential treatment for colorectal cancerZecheng Chen, Aranapakam M Venkatesan, Christoph M Dehnhardt, et al.
Brachytherapy|September 16, 2023
Uncertainty in magnetic resonance imaging-based prostate postimplant dosimetry: Results of a 10-person human observer study, and comparisons with automatic postimplant dosimetryJeremiah W Sanders, Chad Tang, Rajat J Kudchadker, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2010
PKI-179: an orally efficacious dual phosphatidylinositol-3-kinase (PI3K)/mammalian target of rapamycin (mTOR) inhibitorAranapakam M Venkatesan, Zecheng Chen, Osvaldo dos Santos, et al.
Infection and Immunity|June 22, 1999
Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602T S Coster, C W Hoge, L L VanDeVerg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 12, 2018
Time Interval to Biochemical Failure as a Surrogate End Point in Locally Advanced Prostate Cancer: Analysis of Randomized Trial NRG/RTOG 9202James J Dignam, Daniel A Hamstra, Herbert Lepor, et al.
Bioorganic & Medicinal Chemistry Letters|December 9, 2009
Novel purine and pyrazolo[3,4-d]pyrimidine inhibitors of PI3 kinase-alpha: Hit to lead studiesAdam M Gilbert, Pawel Nowak, Natasja Brooijmans, et al.
Human Vaccines & Immunotherapeutics|February 23, 2019
A phase I trial of WRSS1, a <i>Shigella sonnei</i> live oral vaccine in Bangladeshi adults and childrenRubhana Raqib, Protim Sarker, K Zaman, et al.
Surgery|December 6, 2011
Comparison of 6-18F-fluoro-L-DOPA, 18F-2-deoxy-D-glucose, CT, and MRI in patients with pancreatic neuroendocrine neoplasms with von Hippel-Lindau diseaseMio Kitano, Corina Millo, Reza Rahbari, et al.
International Journal of General Medicine|August 27, 2025
Impact of Active Surveillance on Nephrometric Scores of Bosniak III and IV Renal CystsRoberto Dias Machado, Leonardo Bernardes De Amaro, Alessandro Prudente, et al.
Softwarex|June 11, 2021
Deep learning application engine (DLAE): Development and integration of deep learning algorithms in medical imagingJeremiah W Sanders, Justin R Fletcher, Steven J Frank, et al.
Pageof 33

Showing results (231-240 of 321) with videos related to

Sort By:
Pageof 33
Bioorganic & Medicinal Chemistry Letters|July 31, 2009
2,4-Diamino-quinazolines as inhibitors of beta-catenin/Tcf-4 pathway: Potential treatment for colorectal cancerZecheng Chen, Aranapakam M Venkatesan, Christoph M Dehnhardt, et al.
Brachytherapy|September 16, 2023
Uncertainty in magnetic resonance imaging-based prostate postimplant dosimetry: Results of a 10-person human observer study, and comparisons with automatic postimplant dosimetryJeremiah W Sanders, Chad Tang, Rajat J Kudchadker, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2010
PKI-179: an orally efficacious dual phosphatidylinositol-3-kinase (PI3K)/mammalian target of rapamycin (mTOR) inhibitorAranapakam M Venkatesan, Zecheng Chen, Osvaldo dos Santos, et al.
Infection and Immunity|June 22, 1999
Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602T S Coster, C W Hoge, L L VanDeVerg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 12, 2018
Time Interval to Biochemical Failure as a Surrogate End Point in Locally Advanced Prostate Cancer: Analysis of Randomized Trial NRG/RTOG 9202James J Dignam, Daniel A Hamstra, Herbert Lepor, et al.
Bioorganic & Medicinal Chemistry Letters|December 9, 2009
Novel purine and pyrazolo[3,4-d]pyrimidine inhibitors of PI3 kinase-alpha: Hit to lead studiesAdam M Gilbert, Pawel Nowak, Natasja Brooijmans, et al.
Human Vaccines & Immunotherapeutics|February 23, 2019
A phase I trial of WRSS1, a <i>Shigella sonnei</i> live oral vaccine in Bangladeshi adults and childrenRubhana Raqib, Protim Sarker, K Zaman, et al.
Surgery|December 6, 2011
Comparison of 6-18F-fluoro-L-DOPA, 18F-2-deoxy-D-glucose, CT, and MRI in patients with pancreatic neuroendocrine neoplasms with von Hippel-Lindau diseaseMio Kitano, Corina Millo, Reza Rahbari, et al.
International Journal of General Medicine|August 27, 2025
Impact of Active Surveillance on Nephrometric Scores of Bosniak III and IV Renal CystsRoberto Dias Machado, Leonardo Bernardes De Amaro, Alessandro Prudente, et al.
Softwarex|June 11, 2021
Deep learning application engine (DLAE): Development and integration of deep learning algorithms in medical imagingJeremiah W Sanders, Justin R Fletcher, Steven J Frank, et al.
Pageof 33